Deep Branch Biotechnology: Funding, Investors & Team (Sep 2026)
Deep Branch Biotechnology is developing scalable technology that transforms the polluters of today into the producers of tomorrow. They generate clean, nutritious and sustainable single cell protein directly from carbon dioxide present in industrial waste gas, thereby reducing the carbon footprint of emitters and providing sustainable alternatives to soy and fishmeal for the feed industry.
Deep Branch Biotechnology has raised $8.0M across 1 funding round on record, the most recent a Series A of $8.0M announced in Mar 2021.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Deep Branch Biotechnology Company Profile and Key Stats
Latest funding round on record: Mar 2021.
Deep Branch Biotechnology Funding Rounds
Deep Branch Biotechnology Founders and Leadership Team
Contact details for the Deep Branch Biotechnology team: 1 of 1 has an email address on file.
Start 14-day free trial →Deep Branch Biotechnology Funding Compared to Other Biotechnology Startups
Deep Branch Biotechnology's latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Deep Branch Biotechnology in Biotechnology and Nottingham
Companies Similar to Deep Branch Biotechnology
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Deep Branch Biotechnology Funding FAQs
What does Deep Branch Biotechnology do?
Deep Branch Biotechnology is developing scalable technology that transforms the polluters of today into the producers of tomorrow. They generate clean, nutritious and sustainable single cell protein directly from carbon dioxide present in industrial waste gas, thereby reducing the carbon footprint of emitters and providing sustainable alternatives to soy and fishmeal for the feed industry.
How much funding has Deep Branch Biotechnology raised?
Deep Branch Biotechnology has raised $8.0M across 1 round on record. The most recent is a Series A of $8.0M announced in Mar 2021.
When did Deep Branch Biotechnology last raise funding?
Deep Branch Biotechnology's most recent funding round on record is a Series A of $8.0M, announced in Mar 2021.
Who is the CEO of Deep Branch Biotechnology?
Peter Rowe is listed as CEO at Deep Branch Biotechnology.
Where is Deep Branch Biotechnology headquartered?
Deep Branch Biotechnology is based in Nottingham, United Kingdom.
How many employees does Deep Branch Biotechnology have?
Deep Branch Biotechnology is in the 11-50 employee band.
How does Deep Branch Biotechnology's funding compare to other Biotechnology startups?
Deep Branch Biotechnology's latest round of $8.0M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Deep Branch Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Deep Branch Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.